Strong Revenue Growth
Net sales increased 9.2% in Q2 2025, and 6.8% on an organic basis, driven by robust GLP-1 elastomer growth and HVP components. Adjusted diluted EPS increased by 21.1% compared to Q2 2024.
Proprietary Products Segment Performance
Proprietary Products segment saw an 8.4% organic growth, with HVP components increasing 11.3% in the quarter.
HVP Delivery Devices Growth
Revenues from HVP Delivery Devices increased by 30% in Q2 2025, driven by Daikyo Crystal Zenith containment and administration systems.
Upgraded Guidance for 2025
Full-year 2025 revenue guidance increased to $3.04 billion to $3.06 billion from the previous range of $2.945 billion to $2.975 billion.
Improving Gross Profit Margins
Gross profit margin increased by 290 basis points year-over-year to 35.7% in Q2 2025.
Positive Currency Impact
A favorable foreign currency environment contributed a $16.5 million tailwind to revenue in Q2 2025.